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Abstract: A patient with acquired immunodeﬁ  ciency syndrome (AIDS) developed crytpococcal 
meningitis, complicated by papilledema and severe progressive visual loss despite medical 
therapy. Bilateral optic sheath fenestration resulted in signiﬁ  cant improvement in vision and 
resolution of papilledema. Histopathologic evaluation of the optic nerve sheath demonstrated 
numerous cryptococci. Optic nerve sheath fenestration may be an effective treatment method 
when high intracranial pressure is contributing to visual loss, even in the presence of involvement 
of the optic nerve sheath by the fungus.
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Introduction
Visual loss in cryptococcal meningitis may occur from chronically elevated intracra-
nial pressure, adhesive arachnoiditis, or direct invasion of the visual sensory pathway 
by the organism (Kupfer and McCrane 1974; Ofner and Baker 1987; Tan 1988; Lipson 
et al 1989; Garrity et al 1993). Medical therapy with antifungal agents and surgical 
treatment, directed towards lowering the increased intracranial pressure, have met 
with variable success. There are, however, several reports of successful treatment 
of papilledema and visual loss by surgical methods, even in the presence of direct 
invasion of the brain tissues by the organism (Garrity et al 1993; Tan 1988). Our 
patient similarly experienced a remarkable improvement in vision and papilledema 
after optic nerve sheath fenestration despite the presence of cryptococcus in the optic 
nerve sheath.
Case report
A 25-year-old patient with acquired immunodeﬁ  ciency syndrome (AIDS) developed 
headaches, seizures, altered mental status, and visual loss. Lumbar puncture showed 
markedly increased opening cerebral spinal ﬂ  uid (CSF) pressure; cryptococcal organ-
isms were identiﬁ  ed by India ink preparation and in culture. Despite medical treatment 
with intravenous amphotericin B and oral ﬂ  uconazole for cryptococcal meningitis, 
visual loss progressed to 20/200 OD and light perception OS within several weeks. 
Ophthalmoscopy revealed bilateral optic nerve edema (Figure 1A). Magnetic resonance 
imaging showed leptomeningeal and optic nerve enhancement without hydrocephalus 
(Figure 2). Because of progressive severe visual loss despite medical management, 
and in light of increased intracranial pressure and papilledema, the patient was recom-
mended to have bilateral optic nerve sheath fenestration.
Histopathologic evaluation of the (bilateral) optic nerve sheath fenestration speci-
men revealed inﬁ  ltration of the meninges by yeast-form organisms, consistent with 
cryptococci (Figure 3). Two weeks after surgery, the patient’s optic nerve edema 
resolved (Figure 1B) and vision improved to 20/80 OD and hand motions OS.Clinical Ophthalmology 2008:2(3) 638
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Discussion
Cryptococcus neoformans is the most common life-threatening 
fungal pathogen that infects patients with AIDS (Garrity 
et al 1993). Cryptococcal infection typically manifests as 
meningitis with secondary ocular involvement. Abnormal 
ocular ﬁ  ndings are seen in about 40% of the patients, with 
papilledema being the most common presenting sign (Lipson 
et al 1989).
The diagnosis of cryptococcal meningitis is suggested 
by a constellation of clinical and radiographic ﬁ  ndings and 
is supported by a diagnostic lumbar puncture. High opening 
pressure and the presence of cryptococcal antigen and organ-
isms in cerebrospinal ﬂ  uid of affected patients are diagnostic 
of cryptococcal meningitis (Ofner and Baker 1987; Tan 1988; 
Lipson et al 1989; Garrity et al 1993).
When the tissue is available for histopathologic diagno-
sis, cryptococcal organisms may be identiﬁ  ed in meningeal 
sheath, subarachnoid space, and, occasionally, within the 
brain parenchyma. This budding yeast has thick gelatinous 
capsule that stain with periodic acid-Schiff, silver, mucicar-
mine, and acid mucopolysaccharide stains. Little reactive 
inﬂ  ammation is seen in surrounding tissues (Ofner and Baker 
1987; Tan 1988; Garrity et al 1993).
Untreated, cryptococcal meningitis is almost always a 
fatal disease. Medical treatment with intravenous ampho-
tericin B and oral ﬂ  uconazole has a guarded prognosis, and 
permanent neurologic and ophthalmologic sequelae are 
common (Tan 1988). Another treatment goal is directed 
toward lowering increased intracranial pressure, which may 
contribute to optic atrophy and visual loss. Repeated lumbar 
punctures, CSF diverting procedures, and optic nerve sheath 
fenestration have met with variable success (Ofner and Baker 
1987; Tan 1988; Garrity et al 1993; Ferreira et al 1997). 
Interestingly, involvement of the brain by cryptococcal organ-
isms has been demonstrated in several patients who beneﬁ  ted 
from a shunting procedure (Tan 1988). Garrity and associates 
(1993) similarly reported visual improvement in two patients 
with cryptococcal meningitis, treated with optic nerve sheath 
fenestration. Cryptococcal organisms were present in dural 
sheath specimens of both patients despite ongoing therapy 
with antifungal medication (Garrity et al 1993). Our patient 
had analogous presentation of decreased vision, optic nerve 
head edema, and increased intracranial pressure. Partial 
visual rehabilitation was achieved following optic nerve 
Figure 2  T1 weighted, axial MRI of the brain with contrast reveals diffuse leptomeningeal 
enhancement (A). T2 weighted, coronal MRI of the brain reveals thickening of the optic 
nerve-meningeal complex (↑) and increased CSF signal in subarachnoid space (B).
Abbreviations: CSF, cerebral spinal ﬂ  uid; MRI, magnetic resonance image.
Figure 3 Budding yeast organisms stain with Gomori methenamine silver stain (A) 
(GMS stain; high power). The capsules of cryptococci stain with mucicarmine stain 
(B) (Mucicarmine stain; high power).
Figure 1 Fundus photograph of the right eye (A) reveals marked optic nerve head 
edema. Same eye, two weeks after optic nerve sheath fenestration with resolution 
of optic nerve head edema (B).Clinical Ophthalmology 2008:2(3) 639
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sheath fenestration despite histopathologically documented 
optic nerve sheath involvement by fungi.
It appears that no single formula can be applied in man-
agement of cryptococcal meningitis. Medical treatment of 
the infection should be aggressively pursued. When high 
intracranial pressure appears to contribute to visual loss, 
optic nerve sheath fenestration may offer a treatment alter-
native to protect the optic nerves from the effects of chronic 
papilledema.
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